{"id":"145f42e6-e72d-5378-b1d5-70cdc52c0404","stable_key":"a9dd23c6-978a-5755-8bd8-f29bd1fe0cda:b3-redox-nadk2-knockdown-activity","predicate":"supports","statement":"NADK2 knockdown reduced measured mitochondrial-fraction NAD kinase activity to 47% of control in HEK293A cells.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"5bd3f707-c0be-5e94-9e39-fb57fd711600","mechanism_event_label":"Reducing the kinase reduced the mitochondrial capacity to make NADP+.","subject":{"id":"eac1269b-354c-52d4-b3e6-26e6cd111632","slug":"nadk2","display_name":"NADK2","entity_type_key":"protein"},"object":{"id":"026cb01f-584d-5190-a231-c5f1f6bb7636","slug":"mitochondrial-nad-kinase-activity","display_name":"Mitochondrial NAD kinase activity","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"5bd3f707-c0be-5e94-9e39-fb57fd711600","stable_key":"a9dd23c6-978a-5755-8bd8-f29bd1fe0cda:b3-redox-nadk2-knockdown-activity-event","event_type":"biochemical_relationship","label":"Reducing the kinase reduced the mitochondrial capacity to make NADP+.","description":"NADK2 knockdown reduced measured mitochondrial-fraction NAD kinase activity to 47% of control in HEK293A cells.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"283ed24b-06a1-50aa-9281-df3bac6ce37e","slug":"nad-plus","display_name":"NAD+","entity_type_key":"small_molecule"},"role":"substrate","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"be6e4670-953f-5a4e-97da-1e536a54e0e4","slug":"nadp-plus","display_name":"NADP+","entity_type_key":"small_molecule"},"role":"assayed product","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"eac1269b-354c-52d4-b3e6-26e6cd111632","slug":"nadk2","display_name":"NADK2","entity_type_key":"protein"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"026cb01f-584d-5190-a231-c5f1f6bb7636","slug":"mitochondrial-nad-kinase-activity","display_name":"Mitochondrial NAD kinase activity","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/niacin-redox-sources/nadk2-2012.fulltext.txt\", \"locator\": \"Results\", \"start_char\": 16830, \"end_char\": 18219, \"file_sha256\": \"65209c0b4ea7220bc95afdd182e40910f2445345172956e85552d5c6db649648\", \"text_sha256\": \"5de49f80d76c73b6a308096c07b330e8d3d53ee28c6a06f4b2a331e4798b45d7\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"siRNA knockdown","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Three days after siRNA transfection","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Scoped experimental observation; no dietary niacin or magnesium deficiency threshold or treatment benefit was tested.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Niacin research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"niacin","display_name":"Niacin (vitamin B3)","entity_type_key":"nutrient_element"}},{"dimension":"organism","value_text":"Homo sapiens","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Reducing the kinase reduced the mitochondrial capacity to make NADP+.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[nadk2-2012] Identification and characterization of a human mitochondrial NAD kinase. (2012). https://pubmed.ncbi.nlm.nih.gov/23212377/ DOI: 10.1038/ncomms2262","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"HEK293A mitochondrial fraction","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"3a0aacb2-1642-59b0-828b-e0dc5f31a8b8","evidence_kind":"source_excerpt","locator":"Lines 925-936","start_line":925,"end_line":936,"excerpt":"### b3-redox-nadk2-knockdown-activity\nNADK2 knockdown reduced measured mitochondrial-fraction NAD kinase activity to 47% of control in HEK293A cells.\nCondition category: machinery_impairment\nnutrient_topic: Niacin research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: Reducing the kinase reduced the mitochondrial capacity to make NADP+.\norganism: Homo sapiens\ntissue_or_cell_type: HEK293A mitochondrial fraction\nexperimental_model: siRNA knockdown\nlimitations: Scoped experimental observation; no dietary niacin or magnesium deficiency threshold or treatment benefit was tested.\nexposure: Three days after siRNA transfection\nevidence_span: {\"source_cache\": \"artifacts/niacin-redox-sources/nadk2-2012.fulltext.txt\", \"locator\": \"Results\", \"start_char\": 16830, \"end_char\": 18219, \"file_sha256\": \"65209c0b4ea7220bc95afdd182e40910f2445345172956e85552d5c6db649648\", \"text_sha256\": \"5de49f80d76c73b6a308096c07b330e8d3d53ee28c6a06f4b2a331e4798b45d7\"}\n[nadk2-2012] Identification and characterization of a human mitochondrial NAD kinase. (2012). https://pubmed.ncbi.nlm.nih.gov/23212377/ DOI: 10.1038/ncomms2262","model_system":"siRNA knockdown","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [nadk2-2012] Identification and characterization of a human mitochondrial NAD kinase. (2012). https://pubmed.ncbi.nlm.nih.gov/23212377/ DOI: 10.1038/ncomms2262","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"a62b7b5b-786a-57e9-85e9-67c6912a5054","stable_key":"import-a9dd23c6-978a-5755-8bd8-f29bd1fe0cda","title":"Niacin: NAD metabolism, deficiency and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"a8cac59639322f74812ce12eef338c2f6c385c04cc4af6ab511fc7c972f0c2e6","revision_id":"bec8fc45-12e7-5f75-a814-5d72ed015d01","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}